AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16421350 — intervention group
Group type: EXPERIMENTAL
Intervention: After-school program (intervention group attending at least 40% of sessions)
Number of subjects: 447
Study 11726677 — intervention group
Group type: EXPERIMENTAL
Intervention: Three response choices
Number of subjects: 60
Study 11726677 — intervention group
Group type: COMPARATOR
Intervention: Five response choices
Number of subjects: 60
Study 11726677 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report feelings questionnaire
Number of subjects: 60
Study 9667296 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microg sufentanil
Number of subjects: 10
Study 9667296 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 10
Study 7544628 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF administration starting on day 0 (group A)
Number of subjects: 75
Study 7544628 — intervention group
Group type: COMPARATOR
Intervention: G-CSF administration starting on day +7 (group B)
Number of subjects: 75
Study 7544628 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF administration (both groups)
Number of subjects: 75
Study 2655719 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 42
Study 2655719 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 42
Study 2655719 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced REM latency (2-night mean ≤ 65.0 min)
Number of subjects: 42
Study 2655719 — intervention group
Group type: COMPARATOR
Intervention: Nonreduced REM latency
Number of subjects: 42
Study 550376 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 micrograms salbutamol (bolus intravenous injection)
Number of subjects: 32
Study 30661551 — intervention group
Group type: EXPERIMENTAL
Intervention: MATCH (modular evidence-based treatment)
Number of subjects: 34
Study 30661551 — intervention group
Group type: EXPERIMENTAL
Intervention: MATCH strategies (Problem Solving and Relaxation skills)
Number of subjects: 34
Study 30661551 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental content (assessing and empathic listening)
Number of subjects: 34
Study 30661551 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider responses
Number of subjects: 34
Study 28194410 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipath NMES
Number of subjects: 12
Study 28194410 — intervention group
Group type: COMPARATOR
Intervention: Conventional NMES
Number of subjects: 12
Study 26475805 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified paramedian interlaminar (mPI) approach
Number of subjects: 62
Study 26475805 — intervention group
Group type: COMPARATOR
Intervention: Transforaminal (TF) approach
Number of subjects: 62
Study 23370978 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% lidocaine spray
Number of subjects: 120
Study 23370978 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 120
Study 23370978 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracuff alkalinized 2% lidocaine
Number of subjects: 120
Study 23370978 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study 20582610 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser and SRP
Number of subjects: 22
Study 20027938 — intervention group
Group type: EXPERIMENTAL
Intervention: EpiCeram
Number of subjects: 121
Study 20027938 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate cream (Cutivate)
Number of subjects: 121
Study 19839994 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone 0.5-2.5 mg/day
Number of subjects: 169
Study 19839994 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone 3-6 mg/day
Number of subjects: 169
Study 19839994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study 15898029 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial canthus single-injection peribulbar anesthesia
Number of subjects: 100
Study 15898029 — intervention group
Group type: COMPARATOR
Intervention: Double-injection peribulbar anesthesia
Number of subjects: 100
Study 12407030 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic vaporizing electrode procedure
Number of subjects: 0
Study 12407030 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 0
Study 12407030 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer second generation techniques
Number of subjects: 0
Study 12407030 — intervention group
Group type: COMPARATOR
Intervention: All techniques compared
Number of subjects: 0
Study 9615558 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus daily OMT (10 to 20 minutes daily)
Number of subjects: 14
Study 9615558 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 14
Study 7648588 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 gas (n = 41)
Number of subjects: 74
Study 7648588 — intervention group
Group type: COMPARATOR
Intervention: Low osmolar contrast material (Omnipaque 240 mgI/ml) (n = 33)
Number of subjects: 74
Study 2669120 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 15
Study 2669120 — intervention group
Group type: COMPARATOR
Intervention: Low-lactose diet
Number of subjects: 15
Study 338089 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic low dose subcutaneous calcium heparin (dose based on body weight)
Number of subjects: 292
Study 338089 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 292
Study 11474245 — intervention group
Group type: EXPERIMENTAL
Intervention: CDDP given before 5-FU
Number of subjects: 83
Study 11474245 — intervention group
Group type: EXPERIMENTAL
Intervention: CDDP given after 5-FU
Number of subjects: 83
Study 11474245 — intervention group
Group type: COMPARATOR
Intervention: Both regimens (CDDP before and after 5-FU)
Number of subjects: 83
Study 30157383 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteriophage treatment (15 mg capsule containing 4 strains of bacteriophages)
Number of subjects: 43
Study 30157383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 30055199 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned care for obesity and risk reduction (PCORR)
Number of subjects: 262
Study 30055199 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 262
Study 30055199 — intervention group
Group type: EXPERIMENTAL
Intervention: PCORR
Number of subjects: 262
Study 30055199 — intervention group
Group type: COMPARATOR
Intervention: EUC
Number of subjects: 262
Study 27043237 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Bacillus subtilis and Enterococcus faecalis) 0.5 g three times daily through a nasogastric feeding tube plus standard preventive strategies
Number of subjects: 235
Study 27043237 — intervention group
Group type: COMPARATOR
Intervention: Standard preventive strategies alone
Number of subjects: 235
Study 27043237 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Bacillus subtilis and Enterococcus faecalis)
Number of subjects: 235
Study 25389284 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised Exercise (SE)
Number of subjects: 98
Study 25389284 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting (ST)
Number of subjects: 98
Study 25389284 — intervention group
Group type: COMPARATOR
Intervention: Optimal Medical Care (OMC)
Number of subjects: 98
Study 22547591 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus carboplatin (nab-PC)
Number of subjects: 1052
Study 22547591 — intervention group
Group type: COMPARATOR
Intervention: solvent-based paclitaxel plus carboplatin (sb-PC)
Number of subjects: 1052
Study 21416916 — intervention group
Group type: EXPERIMENTAL
Intervention: Pérez‐Olmedo protocol (n = 14)
Number of subjects: 42
Study 21416916 — intervention group
Group type: EXPERIMENTAL
Intervention: Williams protocol (n = 15)
Number of subjects: 42
Study 21416916 — intervention group
Group type: EXPERIMENTAL
Intervention: Jeffrey Saal protocol (n = 13)
Number of subjects: 42
Study 17534786 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water immersion (15-min at 13-14 degrees C)
Number of subjects: 17
Study 17534786 — intervention group
Group type: COMPARATOR
Intervention: Control (passive rest)
Number of subjects: 17
Study 16215304 — intervention group
Group type: EXPERIMENTAL
Intervention: S-R plication
Number of subjects: 78
Study 16215304 — intervention group
Group type: COMPARATOR
Intervention: Nesbit procedure
Number of subjects: 78
Study 16215304 — intervention group
Group type: EXPERIMENTAL
Intervention: S-R plication and Nesbit procedure
Number of subjects: 78
Study 12177541 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg methylprednisolone acetate (Depomedrol)
Number of subjects: 61
Study 12177541 — intervention group
Group type: COMPARATOR
Intervention: 2 mL saline (control)
Number of subjects: 61
Study 10459686 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone 100 mg/day
Number of subjects: 0
Study 10459686 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone 50 mg/day
Number of subjects: 0
Study 10459686 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone (50-100 mg/day)
Number of subjects: 0
Study 7776455 — intervention group
Group type: EXPERIMENTAL
Intervention: Ileal low pressure reservoir using the Goodwin cup‐patch principle combined with an afferent ileal tubular segment
Number of subjects: 100
Study 7776455 — intervention group
Group type: EXPERIMENTAL
Intervention: Ileal low pressure reservoir
Number of subjects: 100
Study 7776455 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper tract surveillance with excretory urography, renal ultrasound and serum creatinine estimation
Number of subjects: 100
Study 7776455 — intervention group
Group type: EXPERIMENTAL
Intervention: Video urodynamics
Number of subjects: 100
Study 7776455 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical technique of ileal low pressure reservoir with afferent isoperistaltic ileal segment
Number of subjects: 100
Study 7776455 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional results of the bladder substitute
Number of subjects: 100
Study 2772366 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (PPL) (160‐240 mg/day)
Number of subjects: 24
Study 2772366 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (PDL) and Clopamide (CLP) (PDL 10 mg, CLP 5 mg per tablet, 1-3 tablets based on blood pressure response)
Number of subjects: 24
Study 2772366 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCT) (150‐100 mg/day)
Number of subjects: 24
Study 2772366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 342149 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulphate treatment
Number of subjects: 42
Study 342149 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial low serum zinc
Number of subjects: 42
Study 342149 — intervention group
Group type: EXPERIMENTAL
Intervention: High serum zinc
Number of subjects: 42
Study 30656648 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Directed Therapy (GDT)
Number of subjects: 149
Study 30656648 — intervention group
Group type: COMPARATOR
Intervention: Routine Fluid Treatment (RFT)
Number of subjects: 149
Study 29991358 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy
Number of subjects: 63
Study 29991358 — intervention group
Group type: COMPARATOR
Intervention: Supportive counselling
Number of subjects: 63
Study 26944938 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription Interactive Voice Response (IVR) Talking Prescriptions (Talking Rx) and SMS reminders
Number of subjects: 200
Study 26944938 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 200
Study 24566877 — intervention group
Group type: EXPERIMENTAL
Intervention: STOPP recommendations made by the inpatient geriatric consultation team (IGCT) to ward physicians to discontinue potentially inappropriate medications (PIMs)
Number of subjects: 146
Study 24566877 — intervention group
Group type: COMPARATOR
Intervention: Standard geriatric advice (Control)
Number of subjects: 146
Study 24566877 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up of patients after discharge
Number of subjects: 146
Study 22894574 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 0.5 mg
Number of subjects: 194
Study 22894574 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 3 mg
Number of subjects: 194
Study 22894574 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg
Number of subjects: 194
Study 22894574 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 15 mg
Number of subjects: 194
Study 22894574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study 21114345 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy (DBT)
Number of subjects: 16
Study 17692985 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated‐interferon alpha‐2b (1 microg/kg/week)
Number of subjects: 102
Study 17692985 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated‐interferon plus ribavirin (800 mg/day up to 52 weeks)
Number of subjects: 102
Study 17692985 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype 1 with low viral load at start of therapy
Number of subjects: 102
Study 17692985 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with sustained virological response
Number of subjects: 102
Study 15822043 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (150,000 U) administered by intravenous infusion for 10 minutes before ERCP
Number of subjects: 406
Study 15822043 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered by intravenous infusion for 10 minutes before ERCP
Number of subjects: 406
Study 11176594 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal incision palatopharyngoplasty
Number of subjects: 72
Study 11176594 — intervention group
Group type: COMPARATOR
Intervention: Minimal incision palatopharyngoplasty with individualized pharyngeal flap or sphincter pharyngoplasty
Number of subjects: 72
Study 9084463 — intervention group
Group type: EXPERIMENTAL
Intervention: CP-148,623 (300 mg twice a day; n = 12)
Number of subjects: 25
Study 9084463 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 25
Study 7941580 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous phototherapy
Number of subjects: 596
Study 7941580 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy
Number of subjects: 596
Study 7941580 — intervention group
Group type: EXPERIMENTAL
Intervention: Exchange transfusion and phototherapy
Number of subjects: 596
Study 7941580 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy (all methods)
Number of subjects: 596
Study 3345017 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g activated charcoal
Number of subjects: 8
Study 3345017 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g activated charcoal-sorbitol solution
Number of subjects: 8
Study 3345017 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 8
Study 30358871 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 antagonist exendin 9-39
Number of subjects: 64
Study 30358871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 28962966 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective Laser Trabeculoplasty (SLT)
Number of subjects: 72
Study 26154030 — intervention group
Group type: EXPERIMENTAL
Intervention: EXPL (1.61 g protein/100 kcal; modified bovine whey proteins with caseinoglycomacropeptide removed)
Number of subjects: 0
Study 26154030 — intervention group
Group type: COMPARATOR
Intervention: CTRL (2.15 g protein/100 kcal; unmodified bovine milk protein with a whey/casein ratio of 60/40)
Number of subjects: 0
Study 26154030 — intervention group
Group type: EXPERIMENTAL
Intervention: BF (breast-fed infants)
Number of subjects: 0
Study 23453018 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified LiuJunZi decoction
Number of subjects: 160
Study 23453018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 21625125 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic data capture
Number of subjects: 52
Study 21625125 — intervention group
Group type: COMPARATOR
Intervention: Handwritten data capture
Number of subjects: 52
Study 18343200 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 18
Study 18343200 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 18
Study 16354710 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietetic assistants (DAs)
Number of subjects: 318
Study 12721161 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovulation induction (OI) with clomiphene (CC) or gonadotrophin (FSH) and intrauterine insemination (IUI)
Number of subjects: 0
Study 12721161 — intervention group
Group type: EXPERIMENTAL
Intervention: FSH/IUI
Number of subjects: 0
Study 12721161 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovulation induction (OI) with IUI
Number of subjects: 0
Study 12721161 — intervention group
Group type: COMPARATOR
Intervention: IVF
Number of subjects: 0
Study 10856867 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermic CPB
Number of subjects: 50
Study 10856867 — intervention group
Group type: COMPARATOR
Intervention: Normothermic CPB
Number of subjects: 50
Study 9416653 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptic dosage reduction (tapered by 25% each month)
Number of subjects: 27
Study 9416653 — intervention group
Group type: COMPARATOR
Intervention: Neuroleptic-free patients (n=19)
Number of subjects: 27
Study 9416653 — intervention group
Group type: COMPARATOR
Intervention: Maintenance on neuroleptics (n=22)
Number of subjects: 27
Study 7962514 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound screening for hip dysplasia
Number of subjects: 4459
Study 7962514 — intervention group
Group type: EXPERIMENTAL
Intervention: Interobserver study of ultrasound method
Number of subjects: 4459
Study 7962514 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidence of late-detected hip dysplasia
Number of subjects: 4459
Study 3298418 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 37
Study 3298418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 31963802 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (HD: 13 g of EAAS BID)
Number of subjects: 25
Study 31963802 — intervention group
Group type: COMPARATOR
Intervention: Low dose (LD: 8 g of EAAS BID)
Number of subjects: 25
Study 29196046 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label intravenous ceftriaxone 2000 mg in addition to usual care
Number of subjects: 2672
Study 29196046 — intervention group
Group type: COMPARATOR
Intervention: Usual care (fluid resuscitation and supplementary oxygen)
Number of subjects: 2672
Study 26597649 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisexual targets
Number of subjects: 1379
Study 26597649 — intervention group
Group type: EXPERIMENTAL
Intervention: Female bisexuality
Number of subjects: 1379
Study 26597649 — intervention group
Group type: EXPERIMENTAL
Intervention: Views of bisexual people
Number of subjects: 1379
Study 25404142 — intervention group
Group type: EXPERIMENTAL
Intervention: Op Volle Kracht (OVK)
Number of subjects: 1341
Study 25404142 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1341
Study 22540955 — intervention group
Group type: EXPERIMENTAL
Intervention: Drain group
Number of subjects: 93
Study 22540955 — intervention group
Group type: COMPARATOR
Intervention: No-drain group
Number of subjects: 93
Study 20118341 — intervention group
Group type: EXPERIMENTAL
Intervention: Subfascial endoscopic perforating surgery (SEPS)
Number of subjects: 0
Study 20118341 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous thermal ablation techniques (PAPS)
Number of subjects: 0
Study 20118341 — intervention group
Group type: EXPERIMENTAL
Intervention: Sclerotherapy of ICPVs (liquid or foam)
Number of subjects: 0
Study 18559416 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation
Number of subjects: 161
Study 18559416 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fat restriction
Number of subjects: 161
Study 18559416 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation and dietary fat restriction combined
Number of subjects: 161
Study 16899026 — intervention group
Group type: EXPERIMENTAL
Intervention: B-CPC (Toothbrushing with dentifrice followed by CPC mouthrinse)
Number of subjects: 29
Study 16899026 — intervention group
Group type: EXPERIMENTAL
Intervention: B-W-CPC (Toothbrushing with dentifrice followed by water rinse and then CPC mouthrinse)
Number of subjects: 29
Study 16899026 — intervention group
Group type: EXPERIMENTAL
Intervention: B-60 min.-CPC (Toothbrushing with dentifrice and waiting 60 min. prior to CPC mouthrinse)
Number of subjects: 29
Study 16899026 — intervention group
Group type: COMPARATOR
Intervention: B-W (Toothbrushing with dentifrice followed by a water rinse, negative control)
Number of subjects: 29
Study 12175665 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (30 mg intravenous bolus and 1 mg/kg subcutaneous injections twice daily for 3-8 days)
Number of subjects: 496
Study 12175665 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 496
Study 9635630 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate 7.5 mg
Number of subjects: 100
Study 9635630 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate 3.75 mg
Number of subjects: 100
Study 9635630 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 9635630 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (both doses)
Number of subjects: 100
Study 7653805 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium 0.15 mg/kg
Number of subjects: 35
Study 2654599 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine and pirenzepine (group 2)
Number of subjects: 30
Study 2654599 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine and placebo (group 1)
Number of subjects: 30
Study 795494 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 0
Study 6113437 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuclear magnetic resonance (NMR) imaging using an inversion recovery technique
Number of subjects: 22
Study 6113437 — intervention group
Group type: COMPARATOR
Intervention: X-ray computed tomography (CT)
Number of subjects: 22